Empresa Regulus Therapeutics Inc Nasdaq
Acciones
US75915K1016
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04/01/16 |
Preston Klassen
PSD | President | 55 | 22/06/23 |
Crispina Calsada
DFI | Director of Finance/CFO | 54 | 30/08/19 |
Rekha Garg
CTO | Chief Tech/Sci/R&D Officer | - | 29/11/22 |
Chief Tech/Sci/R&D Officer | - | 29/11/22 | |
Amin Kamel
PRN | Corporate Officer/Principal | - | 02/06/22 |
Daniel Penksa
AUD | Comptroller/Controller/Auditor | 39 | 01/06/15 |
Christopher Aker
LAW | General Counsel | 63 | 19/05/11 |
Brian K. Campion
PRN | Corporate Officer/Principal | - | 01/07/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 01/06/17 |
David Baltimore
BRD | Director/Board Member | 86 | 01/01/09 |
Director/Board Member | 75 | 01/04/13 | |
Chairman | 75 | 01/01/08 | |
Jake Nunn
BRD | Director/Board Member | 53 | 11/06/19 |
Alice Huang
BRD | Director/Board Member | 85 | 26/01/21 |
Hugh Rosen
BRD | Director/Board Member | 65 | 02/06/16 |
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04/01/16 |
Preston Klassen
PSD | President | 55 | 22/06/23 |
Kathryn Collier
BRD | Director/Board Member | 56 | 17/04/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 3 725 720 | 0 | 0 | 95,99 % |
Acción B | 0 | 258 707 | 0 | 0 | |
Acción C | 0 | 1 330 832 | 0 | 0 | |
Acción D | 1 | 65 465 876 | 64 363 679 ( 98,32 %) | 0 | |
Acción E | 0 | 256 700 | 0 | 0 |
Información de la empresa
Regulus Therapeutics, Inc.
4224 Campus Point Court Suite 210
92121, San Diego
+858 202 6300
http://www.regulusrx.com![Dirección Regulus Therapeutics Inc](https://cdn.zonebourse.com/static/address/11648682.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+15,20 % | 121 mil M | |
+19,67 % | 113 mil M | |
+18,95 % | 26,02 mil M | |
-23,86 % | 19,39 mil M | |
-19,03 % | 15,91 mil M | |
-20,90 % | 15,09 mil M | |
-46,14 % | 15,06 mil M | |
+63,85 % | 14,93 mil M | |
+4,49 % | 13,85 mil M |